HH
DGX icon

Hilltop Holdings’s Quest Diagnostics DGX Stock Holding History

Hilltop Holdings’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$319K Sell
1,504
-2
-0.1% -$393 0.02% 552
2026
Q1 		$295K Sell
1,506
-192
-11% -$37.3K 0.03% 519
2025
Q4 		$295K Buy
1,698
+10
+0.6% +$1.82K 0.02% 724
2025
Q3 		$322K Buy
1,688
+94
+6% +$16.7K 0.02% 719
2025
Q2 		$286K Buy
1,594
+48
+3% +$8.34K 0.02% 706
2025
Q1 		$262K Sell
1,546
-79
-5% -$13K 0.02% 710
2024
Q4 		$245K Hold
1,625
– – 0.02% 732
2024
Q3 		$252K Buy
1,625
+4
+0.2% +$597 0.02% 706
2024
Q2 		$222K Hold
1,621
– – 0.03% 548
2024
Q1 		$216K Hold
1,621
– – 0.02% 585
2023
Q4 		$224K Buy
+1,621
New +$213K 0.03% 542
2023
Q3 		– Sell
-1,621
Closed -$228K – 599
2023
Q2 		$228K Hold
1,621
– – 0.03% 501
2023
Q1 		$229K Buy
1,621
+250
+18% +$35.8K 0.03% 470
2022
Q4 		$214K Buy
+1,371
New +$197K 0.03% 480
2022
Q1 		– Sell
-1,377
Closed -$238K – 564
2021
Q4 		$238K Buy
1,377
+6
+0.4% +$913 0.02% 528
2021
Q3 		$200K Buy
+1,371
New +$201K 0.02% 564
2018
Q3 		– Sell
-2,076
Closed -$228K – 435
2018
Q2 		$228K Sell
2,076
-11
-0.5% -$1.15K 0.05% 358
2018
Q1 		$209K Sell
2,087
-164
-7% -$16.8K 0.04% 367
2017
Q4 		$221K Buy
2,251
+88
+4% +$8.34K 0.05% 307
2017
Q3 		$203K Sell
2,163
-74
-3% -$7.86K 0.06% 267
2017
Q2 		$249K Sell
2,237
-57
-2% -$6.03K 0.07% 280
2017
Q1 		$225K Sell
2,294
-38
-2% -$3.62K 0.07% 292
2016
Q4 		$214K Sell
2,332
-67
-3% -$5.78K 0.07% 299
2016
Q3 		$203K Sell
2,399
-214
-8% -$18K 0.06% 292
2016
Q2 		$213K Buy
+2,613
New +$199K 0.07% 272
2016
Q1 		– Sell
-3,011
Closed -$214K – 299
2015
Q4 		$214K Buy
+3,011
New +$202K 0.06% 298

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Hilltop Holdings's DGX Position: Q2 2026 in Review

Hilltop Holdings reduced its Quest Diagnostics (DGX) stake by 0.13% in Q2 2026, selling an estimated $393 and leaving 1,504 shares worth $319K. The position accounts for 0.02% of the portfolio, ranked #552.

Hilltop Holdings first reported a position in DGX in Q4 2015 and has held it in 26 quarters since. The position peaked at $322K in Q3 2025. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Hilltop Holdings held 1,504 shares of Quest Diagnostics worth $319K as of Q2 2026.
  • Hilltop Holdings sold 2 Quest Diagnostics shares in Q2 2026, an estimated $393.
  • Quest Diagnostics made up 0.02% of Hilltop Holdings's portfolio in Q2 2026, its #552 holding.
  • Hilltop Holdings first reported a position in Quest Diagnostics in Q4 2015 and has held it in 26 quarters since.
  • Hilltop Holdings's Quest Diagnostics position peaked at $322K in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Hilltop Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.